These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
465 related articles for article (PubMed ID: 32295906)
41. Comparison of the biological and biochemical activities of several members of the alphaherpesvirus ICP0 family of proteins. Everett RD; Boutell C; McNair C; Grant L; Orr A J Virol; 2010 Apr; 84(7):3476-87. PubMed ID: 20106921 [TBL] [Abstract][Full Text] [Related]
42. MORC3, a Component of PML Nuclear Bodies, Has a Role in Restricting Herpes Simplex Virus 1 and Human Cytomegalovirus. Sloan E; Orr A; Everett RD J Virol; 2016 Oct; 90(19):8621-33. PubMed ID: 27440897 [TBL] [Abstract][Full Text] [Related]
43. The replication defect of ICP0-null mutant herpes simplex virus 1 can be largely complemented by the combined activities of human cytomegalovirus proteins IE1 and pp71. Everett RD; Bell AJ; Lu Y; Orr A J Virol; 2013 Jan; 87(2):978-90. PubMed ID: 23135716 [TBL] [Abstract][Full Text] [Related]
44. Analysis of the functions of herpes simplex virus type 1 regulatory protein ICP0 that are critical for lytic infection and derepression of quiescent viral genomes. Everett RD; Parsy ML; Orr A J Virol; 2009 May; 83(10):4963-77. PubMed ID: 19264778 [TBL] [Abstract][Full Text] [Related]
45. Components of promyelocytic leukemia nuclear bodies (ND10) act cooperatively to repress herpesvirus infection. Glass M; Everett RD J Virol; 2013 Feb; 87(4):2174-85. PubMed ID: 23221561 [TBL] [Abstract][Full Text] [Related]
46. Proteasome-independent disruption of PML oncogenic domains (PODs), but not covalent modification by SUMO-1, is required for human cytomegalovirus immediate-early protein IE1 to inhibit PML-mediated transcriptional repression. Xu Y; Ahn JH; Cheng M; apRhys CM; Chiou CJ; Zong J; Matunis MJ; Hayward GS J Virol; 2001 Nov; 75(22):10683-95. PubMed ID: 11602710 [TBL] [Abstract][Full Text] [Related]
47. Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0). Maul GG; Guldner HH; Spivack JG J Gen Virol; 1993 Dec; 74 ( Pt 12)():2679-90. PubMed ID: 8277273 [TBL] [Abstract][Full Text] [Related]
48. Distinct temporal roles for the promyelocytic leukaemia (PML) protein in the sequential regulation of intracellular host immunity to HSV-1 infection. Alandijany T; Roberts APE; Conn KL; Loney C; McFarlane S; Orr A; Boutell C PLoS Pathog; 2018 Jan; 14(1):e1006769. PubMed ID: 29309427 [TBL] [Abstract][Full Text] [Related]
49. Recruitment of herpes simplex virus type 1 transcriptional regulatory protein ICP4 into foci juxtaposed to ND10 in live, infected cells. Everett RD; Sourvinos G; Orr A J Virol; 2003 Mar; 77(6):3680-9. PubMed ID: 12610143 [TBL] [Abstract][Full Text] [Related]
50. Role of ND10 nuclear bodies in the chromatin repression of HSV-1. Gu H; Zheng Y Virol J; 2016 Apr; 13():62. PubMed ID: 27048561 [TBL] [Abstract][Full Text] [Related]
51. Alphaherpesvirus proteins related to herpes simplex virus type 1 ICP0 affect cellular structures and proteins. Parkinson J; Everett RD J Virol; 2000 Nov; 74(21):10006-17. PubMed ID: 11024129 [TBL] [Abstract][Full Text] [Related]
52. Herpes simplex virus immediate-early protein ICP0 is targeted by SIAH-1 for proteasomal degradation. Nagel CH; Albrecht N; Milovic-Holm K; Mariyanna L; Keyser B; Abel B; Weseloh B; Hofmann TG; Eibl MM; Hauber J J Virol; 2011 Aug; 85(15):7644-57. PubMed ID: 21632771 [TBL] [Abstract][Full Text] [Related]
53. Reciprocal activities between herpes simplex virus type 1 regulatory protein ICP0, a ubiquitin E3 ligase, and ubiquitin-specific protease USP7. Boutell C; Canning M; Orr A; Everett RD J Virol; 2005 Oct; 79(19):12342-54. PubMed ID: 16160161 [TBL] [Abstract][Full Text] [Related]
54. Regulation of ICP0-null mutant herpes simplex virus type 1 infection by ND10 components ATRX and hDaxx. Lukashchuk V; Everett RD J Virol; 2010 Apr; 84(8):4026-40. PubMed ID: 20147399 [TBL] [Abstract][Full Text] [Related]
56. STAT-1- and IRF-3-dependent pathways are not essential for repression of ICP0-null mutant herpes simplex virus type 1 in human fibroblasts. Everett RD; Young DF; Randall RE; Orr A J Virol; 2008 Sep; 82(17):8871-81. PubMed ID: 18579584 [TBL] [Abstract][Full Text] [Related]
57. Functional characterization of residues required for the herpes simplex virus 1 E3 ubiquitin ligase ICP0 to interact with the cellular E2 ubiquitin-conjugating enzyme UBE2D1 (UbcH5a). Vanni E; Gatherer D; Tong L; Everett RD; Boutell C J Virol; 2012 Jun; 86(11):6323-33. PubMed ID: 22438555 [TBL] [Abstract][Full Text] [Related]
58. Formation of nuclear foci of the herpes simplex virus type 1 regulatory protein ICP4 at early times of infection: localization, dynamics, recruitment of ICP27, and evidence for the de novo induction of ND10-like complexes. Everett RD; Sourvinos G; Leiper C; Clements JB; Orr A J Virol; 2004 Feb; 78(4):1903-17. PubMed ID: 14747555 [TBL] [Abstract][Full Text] [Related]
59. Interaction between the cellular E3 ubiquitin ligase SIAH-1 and the viral immediate-early protein ICP0 enables efficient replication of Herpes Simplex Virus type 2 in vivo. Czechowicz JS; Nagel CH; Voges M; Spohn M; Eibl MM; Hauber J PLoS One; 2018; 13(8):e0201880. PubMed ID: 30080903 [TBL] [Abstract][Full Text] [Related]